United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Ichnos Glenmark Innovation’s phase 1 study of trispecific antibody shows strong results in myeloma treatment Ichnos Glenmark Innovation (IGI), a collaboration between Glenmark Pharmaceuticals Limited and Ichnos Sciences Inc., has unveiled promising results… byPallavi MadhirajuNovember 6, 2024